Session 4: Risk stratification and prevention in ductal in situ carcinoma

Chairs: Jens Huober (Germany), Jonas Bergh (Sweden)

• Risk stratification in patients with ductal carcinoma in situ (Fraser Symmans, USA)
• Estimating the magnitude of clinical benefit of local therapy in patients with DCIS (Shelley Hwang, USA)
• Estimating the magnitude of clinical benefit of systemic therapy in patients with DCIS (Andrea De Censi, Italy)

BCC2019 PARTICIPANT: PASSWORD in BCC e-mail from March 23.